Omron 2016 Annual Report Download - page 34

Download and view the complete annual report

Please find page 34 of the 2016 Omron annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 102

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102

11-Year Financial and Non-Financial Highlights
FY2005 FY2006 FY2007 FY2008
Operating Results:
　Net sales ¥616,002 ¥723,866 ¥762,985 ¥627,190
　Gross profit 248,642 278,241 293,342 218,522
　Selling, general and administrative expenses (excl. R&D expenses) 149,274 164,167 176,569 164,284
　R&D expenses 50,501 52,028 51,520 48,899
　Operating income (Note 1) 60,782 62,046 65,253 5,339
　EBITDA (Note 2) 91,607 95,968 101,596 38,835
　Net income (loss) attributable to shareholders 35,763 38,280 42,383 (29,172)
Cash Flows:
　Net cash provided by operating activities 51,699 40,539 68,996 31,408
　Net cash used in investing activities (43,020) (47,075) (36,681) (40,628)
　Free cash flow (Note 3) 8,679 (6,536)32,315 (9,220)
　Net cash provided by (used in) financing activities (38,320) (4,697) (34,481)21,867
Financial Position:
　Total assets 589,061 630,337 617,367 538,280
　Cash and cash equivalents 52,285 42,995 40,624 46,631
　Total interest-bearing liabilities 2,468 19,988 18,179 52,970
　Total shareholders’
equity 362,937 382,822 368,502 298,411
Per Share Data:
　Net income (loss) attributable to shareholders (EPS) 151.1 165.0 185.9(132.2)
　Shareholders’
equity 1,548.1 1,660.7 1,662.3 1,355.4
　Cash dividends (Note 4) 30.0 34.0 42.0 25.0
　Dividend payout ratio 19.9%20.6%22.6%ー
Financial Indicators:
　Gross profit margin 40.4%38.4%38.4%34.8%
　Operating income margin 9.9%8.6%8.6%0.9%
　EBITDA margin 14.9%13.3%13.3%6.2%
　Return on invested capital (ROIC) 10.1%9.9%10.4% (7.6%)
　Return on equity (ROE) 10.7%10.3%11.3% (8.7%)
　Ratio of shareholders’
equity to total assets 61.6%60.7%59.7%55.4%
　Total return ratio (Note 5) 47.8%49.7%74.7%ー
　Capital expenditures 40,560 44,447 37,072 36,844
　Depreciation and amortization 30,825 33,922 36,343 33,496
　Ratio of overseas sales 43.4%47.3%52.1%49.7%
Non-Financial Data
　Number of employees 27,408 32,456 35,426 32,583
　Ratio of overseas employees to total employees 61.1%64.9%65.7%63.4%
　Number of patents held (Note 6) 4,538 5,206 5,717 5,205
　Environmental contribution (thousand ton-CO2)
(Note 7)
　CO2 emissions of global production sites (thousand ton-CO2) (Note 8)
Notes: 1. Operating income for fiscal 2005 includes an ¥11,915 million gain recorded on the return of pension assets to the government.
2. EBITDA = Operating income + Depreciation and amortization
3. Free cash flow = Net cash provided by operating activities + Net cash used in investing activities
4. Cash dividends per share represent the amounts applicable to the respective year, including dividends to be paid after the end of the fiscal year.
5. Total return ratio = (Total dividends paid + Amount of shares repurchased) / Net income (loss) attributable to shareholders (does not include repurchases of
　 less than one trading unit)
6. Patent information is as of March 15.
1st Stage Establish a Profit Structure
Concentrate on cost structure reform and
restructure the Company as a profit-generating
business
Achievements
• ROE of 10%
• Withdrew from unprofitable business, spun off
Healthcare Business
• Raised the level of corporate governance to the
global standard
2nd Stage Balance Growth and
Earnings
Reinforce business foundations through
aggressive investment in growth areas,
including M&A, and cost reduction
Achievements
• Increased earnings per share from ¥110.7
(FY2003) to ¥185.9 (FY2007)
3rd Stage Achieve a Growth
Structure
Fortify growth businesses (high profitability)
Revival Stage (February 2009 to March 2011)
Revised 3rd-stage targets due to an abrupt
change in the business environment, implement-
ed cost reductions, and spun off Automotive
Electronic Components Business and Social
Systems, Solutions and Service Business
FY2001 – FY2003 FY2004 – FY2007
Long-Term Management Strategy
Grand Design 2010
GD2010
FY2008 – FY2010
OMRON Corporation and Subsidiaries (As of and for the years ended March 31)
32 OMRON Corporation